Evidence map›Paper›PMID 35945982›Full record

ArticleBiocybernetics and biomedical engineering

COVID-RDNet: A novel coronavirus pneumonia classification model using the mixed dataset by CT and X-rays images.

Lingling Fang, Xin Wang

Abstract read
In one paragraph

Article in Biocybernetics and biomedical engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lingling FangDepartment of Computing and Information Technology, Liaoning Normal University, Dalian City, Liaoning Province, China.
Xin WangDepartment of Computing and Information Technology, Liaoning Normal University, Dalian City, Liaoning Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corona virus disease 2019 (COVID-19) testing relies on traditional screening methods, which require a lot of manpower and material resources. Recently, to effectively reduce the damage caused by radiation and enhance effectiveness, deep learning of classifying COVID-19 negative and positive using the mixed dataset by CT and X-rays images have achieved remarkable research results. However, the details presented on CT and X-ray images have pathological diversity and similarity features, thus increasing the difficulty for physicians to judge specific cases. On this basis, this paper proposes a novel coronavirus pneumonia classification model using the mixed dataset by CT and X-rays images. To solve the problem of feature similarity between lung diseases and COVID-19, the extracted features are enhanced by an adaptive region enhancement algorithm. Besides, the depth network based on the residual blocks and the dense blocks is trained and tested. On the one hand, the residual blocks effectively improve the accuracy of the model and the non-linear COVID-19 features are obtained by cross-layer link. On the other hand, the dense blocks effectively improve the robustness of the model by connecting local and abstract information. On mixed X-ray and CT datasets, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), area under curve (AUC), and accuracy can all reach 0.99. On the basis of respecting patient privacy and ethics, the proposed algorithm using the mixed dataset from real cases can effectively assist doctors in performing the accurate COVID-19 negative and positive classification to determine the infection status of patients.

Indexed as

Adaptive region enhancementCOVID-19Deep learningDense blockMixed dataset

Identifiers

PMID35945982
PMCPMC9353669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.